Sprengerinin C TN5050
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis, it can strongly suppress tumor angiogenesis in human umbilical vein endothelial cells, it blocks vascul
CAS nr:
88861-91-0
Purity:
98%
Molecular Weight:
855
SMILES:
C[C@H]1C2[C@H](C[C@H]3[C@@H]4CC=C5C[C@H](CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)O[C@]11CC[C@@H](C)CO1
Formula:
C44H70O16
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,PI3K/Akt/mTOR signaling,Immunology/Inflammation,PI3K/Akt/mTOR signaling,PI3K/Akt/mTOR signaling,MAPK,Cytoskeletal Signaling,Apoptosis,Immunology/Inflammation
Target:
VEGFR,VEGFR,mTOR,ROS,PI3K,Akt,p38 MAPK,Akt,p53,NADPH-oxidase
